(Q37702257)

22 August 2017

1 reference

title

Drug delivery strategies for therapy of visceral leishmaniasis (English)

1 reference

22 August 2017

main subject

visceral leishmaniasis

1 reference

1 reference

Swati Gupta

1

1 reference

22 August 2017

Ajay Pal

series ordinal

2

1 reference

22 August 2017

Suresh P Vyas

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Expert Opinion on Drug Delivery

22 August 2017

published in

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

371-402

1 reference

Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Optimizing efficacy of amphotericin B through nanomodification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

How do protozoan parasites survive inside macrophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Proteophosphoglycans of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Leishmania major proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Function and assembly of the Leishmania surface coat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Cellular resistance to protozoal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Of microbes and macrophages: entry, survival and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Pentavalent antimonials: new perspectives for old drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Pentamidine uptake and resistance in pathogenic protozoa: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Chemotherapy of leishmaniasis: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Advances in the treatment of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Lipid formulations of amphotericin B: recent progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Liposomal amphotericin B for the treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Developments in the treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vivo interference of paromomycin with mitochondrial activity of Leishmania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Injectable paromomycin for Visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

A policy for leishmaniasis with respect to the prevention and control of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Oral miltefosine for Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Challenges and new discoveries in the treatment of leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Liposomes: realizing their promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Liposome disposition in vivo. III. Dose and vesicle-size effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Commentary. Lysosomotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of antimonials entrapped in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activities of stearylamine-bearing liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Biodegradable Polymers for Protein and Peptide Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Anti-leishmanial activity of a new formulation of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Nanotechnology-based drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of nano-amphotericin B deoxycholate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

The characteristics, isolation and synthesis of the phagocytosis stimulating peptide tuftsin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Tuftsin-macrophage interaction: Specific binding and augmentation of phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Plant natural products with leishmanicidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Natural products as trypanocidal, antileishmanial and antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antiparasitic alkaloids from Psychotria klugii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides: new source of tanshinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of isolated triterpenoids from Pourouma guianensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

New sesquiterpene lactones from Elephantopus mollis and their leishmanicidal activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vitro leishmanicidal activity of monomeric and dimeric naphthoquinones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Trypanocidal and leishmanicidal properties of substitution-containing chalcones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Critical evaluation of the therapeutic potential of bassic acid incorporated in oil-in-water microemulsions and poly-D,L-lactide nanoparticles against experimental leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Liposome-based approaches to overcome anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Ligand-targeted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Biological and chemical studies of Pera benensis, a Bolivian plant used in folk medicine as a treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

New prenylated quinones from Peperomia galioides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

New aporphine alkaloids from guatteria foliosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Pessoine and spinosine, two catecholic berbines from Annona spinescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

[Active antihelminitic alkaloids: active in vitro against Leishmanic Tropica the protozoa involved in leishmaniasis.]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Bisbenzylisoquinoline alkaloids from Guatteria boliviana (Annonaceae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

2-substituted quinoline alkaloids as potential antileishmanial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Peganine hydrochloride dihydrate an orally active antileishmanial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of quinovic acid glycosides and cadambine acid isolated from Nauclea diderrichii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Iridoids: a new class of leishmanicidal agents from Nyctanthes arbortristis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Immunostimulant Activity of Picroliv, the Iridoid Glycoside Fraction of Picrorhiza kurroa, and its Protective Action against Leishmania donovani Infection in Hamsters1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

[Isolation and synthesis of espintanol, a new antiparasitic monoterpene]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Piperogalin, a new prenylated diphenol from Peperomia galioides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

New trichothecenes isolated from Holarrhena floribunda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Saponins of the ivy plant, Hedera helix, and their leishmanicidic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vitro leishmanicidal activity of aurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Absolute configuration and antiprotozoal activity of minquartynoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Evaluation of antileishmanial potential of Tinospora sinensis against experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

An ethanolic extract of leaves of Piper betle (Paan) Linn mediates its antileishmanial activity via apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Screening of plant extracts for antiprotozoal and cytotoxic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antiprotozoal activities of Colombian plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Immunomodulatory principles of Pelargonium sidoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Protective effect of Picroliv from Picrorhiza kurroa against Leishmania donovani infections in Mesocricetus auratus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Evaluation of plant extracts for antileishmanial activity using a mechanism-based radiorespirometric microtechnique (RAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Isolation and biological study of a triterpenoid saponin, mimengoside A, from the leaves of Buddleja madagascariensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Cytotoxic and antiparasitic activity from Annona senegalensis seeds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

An Antileishmanial Chalcone from Chinese Licorice Roots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

The third component of complement (C3) is responsible for the intracellular survival of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903548232

Antiprotozoal activity of dehydrozaluzanin C, a sesquiterpene lactone isolated fromMunnozia maronii (asteraceae)

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/PTR.2650070203

Structure of Mimengosides A and B, New Triterpenoid Glycosides from Buddlejae Flos Produced in China.

10 April 2024

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.40.780

Leishmanicidal and Trypanocidal activities of Acetogenins isolated fromAnnona glauca

1 reference

11 May 2024

https://opencitations.net/index/api/v1/citations/10.1002/(SICI)1099-1573(199812)12:8%3C541::AID-PTR358%3E3.0.CO;2-5

Identifiers

DOI

10.1517/17425240903548232

1 reference

22 August 2017

1 reference